Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Mitra Angkasa Sejahtera Tbk. (BAUT) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Mitra Angkasa Sejahtera Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Mitra Angkasa Sejahtera Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Mitra Angkasa Sejahtera Tbk. trades at Rp35 (market cap 168.01B, 2.65M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 3.8× Mitra Angkasa Sejahtera Tbk.'s market cap, and Mitra Angkasa Sejahtera Tbk. is more actively traded (2.65M versus 843K). Which is the better fit depends on your goals.

BAUTLABS
Market Cap
168.01B635.95B
Volume
2.65M843K
Lot
26.45K8.43K
Turnover
92.26M137.6M
Average Price
34.88163.22
Value
92.26M137.6M
Indicative Equilibrium Price
35165
Indicative Equilibrium Volume
4.53K246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BAUT
View details
LABS
View details

About Mitra Angkasa Sejahtera Tbk.

PT Mitra Angkasa Sejahtera Tbk (“the Company”) is established based on Deed of Establishment No. 63 dated November 19, 2012 made by Doktorandus Wijanto Suwongso, S.H., Notary in Jakarta. The Company started its commercial operations in 2016.

Read more on BAUT

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS